Q1 2026 Earnings Call Transcript October 29, 2025 Microsoft Corporation beats earnings expectations. Reported EPS is $4.13, ...
UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in moderate-to-severe hidradenitis suppurativa (HS). BIMZELX, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback